Bone Biologics's total assets for Q2 2026 were $4.44M, a decrease of -10.90% from the previous quarter. BBLG total liabilities were $512.02K for the fiscal quarter, a 65.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.